Paperpal Prime Logo

Journal of Pathology : Impact Factor & More

eISSN: 1096-9896pISSN: 0022-3417

Aims and Scope of Journal of Pathology

The Journal of Pathology is a peer-reviewed medical journal that was established in 1892 as The Journal of Pathology and Bacteriology by German Sims Woodhead. It has been the official journal of the Pathological Society of Great Britain and Ireland (present name: Pathological Society) since its foundation in 1906. The journal has published important papers in pathology and experimental medicine including work by Rudolf Virchow and Ilya Ilyich Mechnikov, both of whom contributed to the inaugural issue. In 1969, the journal's title was shortened to The Journal of Pathology. In January 1999, the first of an ongoing series of Annual Review issues was published, on the topic of "Molecular and Cellular Themes in Cancer Research", edited by Peter A. Hall and David P. Lane. A history of the journal was written in 2006 by former editor-in-chief C. Simon Herrington, as a chapter of a book on the history of the Pathological Society. Less

Key Metrics

CiteScore
14.1
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
SJR
Q1Pathology and Forensic Medicine
SNIP
1.87
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Pathology

Journal of Pathology Journal Specifications

Overview
Publisher WILEY
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1892
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Pathology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Pathology

FTO-mediated m6A modification of protein disulfide-isomerase activates VEGFA-VEGFR2 to suppress programmed cell death in osteosarcoma.
  • 1 Sep 2026
  • The Journal of pathology
Lipodystrophy and adipose tissue recovery are mediated by the Wnt/lipogenesis axis during skin fibrosis.
  • 1 Sep 2026
  • The Journal of pathology
Aberrant alternative splicing of purinergic receptor P2RX4 prevents sensitivity towards combinatorial treatment in colorectal and pancreatic cancer.
  • 1 Sep 2026
  • The Journal of pathology
Histiocytosis development and clinical variation through the lens of genomics.
  • 1 Sep 2026
  • The Journal of pathology
Tumor Invasive Border Index (TIBI) in colorectal cancer: linking infiltrative morphology to molecular insights.
  • 1 Sep 2026
  • The Journal of pathology
Dopamine inhibits retinal pathological neovascularization in the oxygen-induced retinopathy mouse model.
  • 1 Sep 2026
  • The Journal of pathology
FTO-mediated m6A modification of protein disulfide-isomerase activates VEGFA-VEGFR2 to suppress programmed cell death in osteosarcoma.
  • 1 Sep 2026
  • The Journal of pathology
Lipodystrophy and adipose tissue recovery are mediated by the Wnt/lipogenesis axis during skin fibrosis.
  • 1 Sep 2026
  • The Journal of pathology
Aberrant alternative splicing of purinergic receptor P2RX4 prevents sensitivity towards combinatorial treatment in colorectal and pancreatic cancer.
  • 1 Sep 2026
  • The Journal of pathology
Histiocytosis development and clinical variation through the lens of genomics.
  • 1 Sep 2026
  • The Journal of pathology
Tumor Invasive Border Index (TIBI) in colorectal cancer: linking infiltrative morphology to molecular insights.
  • 1 Sep 2026
  • The Journal of pathology
Dopamine inhibits retinal pathological neovascularization in the oxygen-induced retinopathy mouse model.
  • 1 Sep 2026
  • The Journal of pathology

FAQs on Journal of Pathology